119 related articles for article (PubMed ID: 30694182)
1. [Erythroleukemias. Recategorization according to the World Health Organization's criteria].
Peruzzo LB; Bertone MC; Mathey MD; Rossi JG; Baialardo EM; Felice MS
Medicina (B Aires); 2019; 79(1):1-5. PubMed ID: 30694182
[TBL] [Abstract][Full Text] [Related]
2. An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification.
Qiu S; Jiang E; Wei H; Lin D; Zhang G; Wei S; Zhou C; Liu K; Wang Y; Liu B; Liu Y; Gong B; Gong X; Feng S; Mi Y; Han M; Wang J
BMC Cancer; 2017 Aug; 17(1):534. PubMed ID: 28793875
[TBL] [Abstract][Full Text] [Related]
3. Acute erythroid leukemia.
Zuo Z; Polski JM; Kasyan A; Medeiros LJ
Arch Pathol Lab Med; 2010 Sep; 134(9):1261-70. PubMed ID: 20807044
[TBL] [Abstract][Full Text] [Related]
4. Shifting of erythroleukemia to myelodysplastic syndrome according to the revised WHO classification: Biologic and cytogenetic features of shifted erythroleukemia.
Ryu S; Park HS; Kim SM; Im K; Kim JA; Hwang SM; Yoon SS; Lee DS
Leuk Res; 2018 Jul; 70():13-19. PubMed ID: 29729583
[TBL] [Abstract][Full Text] [Related]
5. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease.
Kasyan A; Medeiros LJ; Zuo Z; Santos FP; Ravandi-Kashani F; Miranda R; Vadhan-Raj S; Koeppen H; Bueso-Ramos CE
Mod Pathol; 2010 Aug; 23(8):1113-26. PubMed ID: 20473273
[TBL] [Abstract][Full Text] [Related]
6. Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.
Calvo X; Arenillas L; Luño E; Senent L; Arnan M; Ramos F; Ardanaz MT; Pedro C; Tormo M; Montoro J; Díez-Campelo M; Arrizabalaga B; Xicoy B; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L
Mod Pathol; 2016 Dec; 29(12):1541-1551. PubMed ID: 27562492
[TBL] [Abstract][Full Text] [Related]
7. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
8. Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics: A Guide to a Number of Perplexing Entities.
Wang SA; Hasserjian RP
Am J Clin Pathol; 2015 Jul; 144(1):44-60. PubMed ID: 26071461
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases.
Kowal-Vern A; Mazzella FM; Cotelingam JD; Shrit MA; Rector JT; Schumacher HR
Am J Hematol; 2000 Sep; 65(1):5-13. PubMed ID: 10936857
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features and outcome of acute erythroid leukemia based on 2008 revised World Health Organization classification.
Liu CJ; Hong YC; Yang CF; Liu SH; Gau JP; Liu JH; Hsiao LT; Liu CY; Yu YB; Tzeng CH
Leuk Lymphoma; 2012 Feb; 53(2):289-94. PubMed ID: 21780998
[TBL] [Abstract][Full Text] [Related]
11. Pure erythroid leukemia.
Wang W; Wang SA; Medeiros LJ; Khoury JD
Am J Hematol; 2017 Mar; 92(3):292-296. PubMed ID: 28006859
[TBL] [Abstract][Full Text] [Related]
12. Erythroleukemia: a need for a new definition.
Park S; Picard F; Dreyfus F
Leukemia; 2002 Aug; 16(8):1399-401. PubMed ID: 12145675
[TBL] [Abstract][Full Text] [Related]
13. Revisiting erythroleukemia.
Arber DA
Curr Opin Hematol; 2017 Mar; 24(2):146-151. PubMed ID: 27875373
[TBL] [Abstract][Full Text] [Related]
14. The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS.
Alkharabsheh O; Al-Kali A; Saadeh S; He R; Viswanatha D; Greipp P; Reichard K; Shah M; Gangat N; Patnaik M; Hogan W; Litzow M; Alkhateeb H; Nguyen PL
Am J Hematol; 2018 Nov; 93(11):E355-E357. PubMed ID: 30074268
[No Abstract] [Full Text] [Related]
15. Childhood acute erythroleukemia diagnosis by flow cytometry.
Sharma A; Buxi G; Walia R; Yadav RB; Sharma S
Indian J Pathol Microbiol; 2011; 54(1):173-5. PubMed ID: 21393910
[TBL] [Abstract][Full Text] [Related]
16. Erythroleukemia-historical perspectives and recent advances in diagnosis and management.
Boddu P; Benton CB; Wang W; Borthakur G; Khoury JD; Pemmaraju N
Blood Rev; 2018 Mar; 32(2):96-105. PubMed ID: 28965757
[TBL] [Abstract][Full Text] [Related]
17. Erythroleukemia: a review of 15 cases meeting 1985 FAB criteria and survey of the literature.
Atkinson J; Hrisinko MA; Weil SC
Blood Rev; 1992 Dec; 6(4):204-14. PubMed ID: 1486289
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic criteria for acute erythroleukemia.
Selby DM; Valdez R; Schnitzer B; Ross CW; Finn WG
Blood; 2003 Apr; 101(7):2895-6. PubMed ID: 12642345
[No Abstract] [Full Text] [Related]
19. Erythroleukemia: a comparison between the previous FAB approach and the WHO classification.
Park S; Picard F; Azgui Z; Viguie F; Merlat A; Guesnu M; Leblond V; Dreyfus F
Leuk Res; 2002 May; 26(5):423-9. PubMed ID: 11916513
[TBL] [Abstract][Full Text] [Related]
20. Cell markers in the recognition of acute myeloblastic leukaemia subtypes.
Andoljsek D; Preloznik Zupan I; Zontar D; Cernelc P; Mlakar U; Modic M; Pretnar J; Zver S
Cell Mol Biol Lett; 2002; 7(2):343-5. PubMed ID: 12097981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
